Historical comparison of prophylactic ganciclovir for gastrointestinal cytomegalovirus infection in kidney transplant recipients.

[1]  C. Mengelle,et al.  Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus‐seropositive kidney‐transplant patients , 2008, Journal of medical virology.

[2]  O. Hes,et al.  Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  J. Stoner,et al.  Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients , 2005, Annals of Internal Medicine.

[4]  K. Salmela,et al.  Gastroduodenal cytomegalovirus infection is common in kidney transplantation patients , 2005, Scandinavian journal of gastroenterology.

[5]  J. Preiksaitis,et al.  Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in Solid Organ Transplantation Final Report , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  T. Hibi,et al.  Clinical significance of cytomegalovirus ( CMV ) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation , 2004 .

[7]  H. Rollag,et al.  A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1 , 2000, Transplantation.

[8]  C. V. van Buren,et al.  THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON SERONEGATIVE RECIPIENTS OF SEROPOSITIVE DONOR KIDNEYS VERSUS SEROPOSITIVE RECIPIENTS TREATED WITH CYCLOSPORINE‐PREDNISONE IMMUNOSUPPRESSION , 1988, Transplantation.